Cochlear Implant Unilateral denied as not FDA-approved for this use by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for cochlear implant unilateral are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denied Your Cochlear Implant as "Not FDA-Approved"

This denial reason is almost always applied in error for cochlear implants, because cochlear implant systems have held FDA approval for decades and the devices used in clinical practice are FDA-cleared. The more likely explanation is a coding or administrative mismatch — perhaps a claim was submitted under a device code or procedure code that UHC's system did not recognize as the approved product, or the denial was generated automatically without accurate review of the submitted device documentation.

## Why This Is Appealable

A "not FDA-approved" denial can be overturned when you document that the specific device implanted (or recommended for implantation) is in fact FDA-approved. Your audiologist and surgeon will have the device manufacturer's name and model number on record, along with the FDA approval letter or the device's FDA 510(k)/PMA number, all of which can be submitted to contradict the denial.

## The Federal Appeal Framework

• Internal appeal (Level 1): Required first step under ACA Section 2719 and ERISA Section 503. Submit within the deadline stated in your denial letter (commonly 180 days for non-grandfathered plans). UHC must issue a decision within 30 days for pre-service requests or 60 days for post-service claims.
• External review: If the internal appeal fails, you have the right to an independent external review under ACA Section 2719. You generally have four months from the final internal denial to request external review. An accredited Independent Review Organization (IRO) — not UHC — makes the binding decision.
• Expedited option: If the standard timeline would seriously jeopardize your health, request expedited internal and external review; decisions are typically required within 72 hours.

## Documentation to Gather

• Device approval documentation: The FDA approval or clearance number for the specific cochlear implant system; the manufacturer product sheet.
• Diagnosis confirmation: Audiology evaluation confirming diagnosis and severity of hearing loss, and documentation that the patient meets candidacy criteria per the prescribing label and applicable professional society guidelines (e.g., American Academy of Otolaryngology–Head and Neck Surgery guidelines).
• Prescriber medical-necessity letter: A letter from the implanting surgeon or audiologist affirming the device is FDA-approved, explaining why it is medically necessary, and rebutting the specific denial basis point by point.
• Operative or procedure notes (if post-service) documenting the specific device used.

## Criteria-Mapping Structure

For each basis UHC cited in the denial, list it explicitly and answer it with a chart fact:

| UHC Denial Basis | Supporting Documentation | |---|---| | Device not FDA-approved | FDA PMA/510(k) number from manufacturer; surgeon's device selection note | | Specific model or system not covered | UHC's own coverage policy for cochlear implants; confirm device is on covered list |

Obtain UHC's published coverage policy for cochlear implants directly from UHC's provider or member portal, and compare each requirement to your clinical record line by line before submitting.